González-Barón M - Search Results

1

Phospholipid hydroperoxide glutathione peroxidase (PHGPx) expression is downregulated in poorly differentiated breast invasive ductal carcinoma.

Cejas P, García-Cabezas MA, Casado E, Belda-Iniesta C, De Castro J, Fresno JA, Sereno M, Barriuso J, Espinosa E, Zamora P, Feliu J, Redondo A, Hardisson DA, Renart J, González-Barón M. Cejas P, et al. Free Radic Res. 2007 Jun;41(6):681-7. doi: 10.1080/10715760701286167. Free Radic Res. 2007. PMID: 17516241

2

Localisation of COX-2 protein is different in breast ductal carcinoma and adjacent non-tumour ductal epithelium.

Cejas P, García-Cabezas MA, Casado E, Barriuso J, Fresno JA, Díaz E, Belda-Iniesta C, Castro J, Espinosa E, Zamora P, Feliu J, Redondo A, Hardisson DA, González-Barón M. Cejas P, et al. Clin Transl Oncol. 2005 Jul;7(6):239-43. doi: 10.1007/BF02710169. Clin Transl Oncol. 2005. PMID: 16131446

3

beta-catenin expression pattern in primary oesophageal squamous cell carcinoma. Relationship with clinicopathologic features and clinical outcome.

de Castro J, Gamallo C, Palacios J, Moreno-Bueno G, Rodríguez N, Feliu J, González-Barón M. de Castro J, et al. Virchows Arch. 2000 Dec;437(6):599-604. doi: 10.1007/s004280000266. Virchows Arch. 2000. PMID: 11193470

4

Molecular markers in colorectal cancer: genetic bases for a customised treatment.

Casado E, De Castro J, Belda-Iniesta C, Cejas P, Feliu J, Sereno M, González-Barón M. Casado E, et al. Clin Transl Oncol. 2007 Sep;9(9):549-54. doi: 10.1007/s12094-007-0102-8. Clin Transl Oncol. 2007. PMID: 17921101 Review.

5

Immunohistochemical analysis of tumour regression grade for rectal cancer after neoadjuvant chemoradiotherapy.

García VM, Batlle JF, Casado E, Burgos E, de Castro J, Belda C, Barriuso J, Sánchez JJ, García-Cabezas MÁ, González-Barón M, Cejas P. García VM, et al. Among authors: gonzalez baron m. Colorectal Dis. 2011 Sep;13(9):989-98. doi: 10.1111/j.1463-1318.2010.02386.x. Colorectal Dis. 2011. PMID: 20718834

6

Serum albumin and other prognostic factors related to response and survival in patients with advanced non-small cell lung cancer.

Espinosa E, Feliu J, Zamora P, González Barón M, Sánchez JJ, Ordón ez A, Espinosa J. Espinosa E, et al. Lung Cancer. 1995 Mar;12(1-2):67-76. doi: 10.1016/0169-5002(95)00407-r. Lung Cancer. 1995. PMID: 7600032

7

[Glucocorticoids in oncology].

de Castro J, Zamora P, González Barón M. de Castro J, et al. Med Clin (Barc). 1995 Mar 11;104(9):349-56. Med Clin (Barc). 1995. PMID: 7731305 Review. Spanish. No abstract available.

8

[The use of high-dose chemotherapy in the treatment of breast cancer].

Espinosa E, Zamora P, González Barón M. Espinosa E, et al. Med Clin (Barc). 1996 Jun 8;107(2):56-8. Med Clin (Barc). 1996. PMID: 8753896 Review. Spanish. No abstract available.

9

[An outlook on the future in oncology research in Spain].

Espinosa E, Zamora P, González Barón M. Espinosa E, et al. Med Clin (Barc). 1999 Oct 30;113(14):541-3. Med Clin (Barc). 1999. PMID: 10605672 Spanish. No abstract available.

10

Failure of goserelin ovarian ablation in premenopausal women with breast cancer: two case reports.

Jiménez-Gordo AM, de las Heras B, Zamora P, Espinosa E, González-Barón M. Jiménez-Gordo AM, et al. Gynecol Oncol. 2000 Jan;76(1):126-7. doi: 10.1006/gyno.1999.5641. Gynecol Oncol. 2000. PMID: 10620455

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

225 results

Search Page

Filters